First conditional marketing authorization approval in the European Union for hemophilia "A" gene therapy

Thierry VandenDriessche1, Steven W Pipe2, Glenn F Pierce3

  • 1Department of Gene Therapy & Regenerative Medicine, Vrije Universiteit Brussel, Brussels, Belgium; Center for Molecular & Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.

Abstract

No abstract available in PubMed .